JP2008001654A - External preparation for skin - Google Patents
External preparation for skin Download PDFInfo
- Publication number
- JP2008001654A JP2008001654A JP2006173908A JP2006173908A JP2008001654A JP 2008001654 A JP2008001654 A JP 2008001654A JP 2006173908 A JP2006173908 A JP 2006173908A JP 2006173908 A JP2006173908 A JP 2006173908A JP 2008001654 A JP2008001654 A JP 2008001654A
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- skin
- poe
- mass
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- -1 amino acid ester Chemical class 0.000 claims abstract description 42
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 25
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 25
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 25
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229940035936 ubiquinone Drugs 0.000 claims abstract description 24
- 230000002378 acidificating effect Effects 0.000 claims abstract description 23
- 150000001413 amino acids Chemical class 0.000 claims abstract description 21
- 150000003862 amino acid derivatives Chemical class 0.000 claims abstract description 17
- DUJPDBHMHIVXOJ-VIFPVBQESA-N (2s)-3-hydroxy-2-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylamino]propanoic acid Chemical compound CC1=NC=C(CO)C(CN[C@@H](CO)C(O)=O)=C1O DUJPDBHMHIVXOJ-VIFPVBQESA-N 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 230000037303 wrinkles Effects 0.000 abstract description 14
- 229940024606 amino acid Drugs 0.000 description 33
- 235000001014 amino acid Nutrition 0.000 description 33
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 230000003020 moisturizing effect Effects 0.000 description 16
- 230000003750 conditioning effect Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229940039717 lanolin Drugs 0.000 description 8
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229940071085 lauroyl glutamate Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229960001153 serine Drugs 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 229960002885 histidine Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- IDHBXJLCYUJUMC-UWVGGRQHSA-N methyl (2r)-2-amino-3-[[(2r)-2-(diacetylamino)-3-methoxy-3-oxopropyl]disulfanyl]propanoate Chemical compound COC(=O)[C@@H](N)CSSC[C@H](N(C(C)=O)C(C)=O)C(=O)OC IDHBXJLCYUJUMC-UWVGGRQHSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 238000004383 yellowing Methods 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- SVETUDAIEHYIKZ-IUPFWZBJSA-N tris[(z)-octadec-9-enyl] phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(=O)(OCCCCCCCC\C=C/CCCCCCCC)OCCCCCCCC\C=C/CCCCCCCC SVETUDAIEHYIKZ-IUPFWZBJSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- CHCZPSBPZFXDQJ-UHFFFAOYSA-L zinc;2-oxopyrrolidine-1-carboxylate Chemical compound [Zn+2].[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O CHCZPSBPZFXDQJ-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤に関し、さらに詳しくは、保湿効果および整肌効果に優れ、かつ、しみ(染み)や皺にたいする改善効果に優れた皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly, to an external preparation for skin having excellent moisturizing effect and skin conditioning effect, and excellent effect of improving stains (stains) and wrinkles.
アミノ酸やアミノ酸誘導体は保湿作用を有することから、それらを配合した皮膚外用剤が提案されているが、アミノ酸やアミノ酸誘導体だけでは必ずしも充分な保湿効果が得られない。 Since amino acids and amino acid derivatives have a moisturizing action, skin external preparations containing them have been proposed. However, sufficient amino acid and amino acid derivatives alone do not always provide a sufficient moisturizing effect.
また、ユビキノンは整肌作用および皮膚賦活作用を有することから、ユビキノンを配合した皮膚外用剤も提案されているが、ユビキノンだけでは必ずしも充分な特性が得られないという問題があった。 Further, since ubiquinone has a skin conditioning action and a skin activation action, an external preparation for skin containing ubiquinone has also been proposed, but there is a problem that sufficient characteristics cannot always be obtained with ubiquinone alone.
そこで、ユビキノンとビタミンA誘導体とを併用して皮膚外用剤を調整することが提案されたり(特許文献1)、ユビキノンと保湿性成分とを併用して保湿化粧料を調整することが提案されている(特許文献2)。 Therefore, it has been proposed to use ubiquinone and a vitamin A derivative in combination to adjust a skin external preparation (Patent Document 1), or to use ubiquinone and a moisturizing component in combination to adjust a moisturizing cosmetic. (Patent Document 2).
しかしながら、それらによっても、保湿効果および整肌効果に優れ、かつ、しみや皺に対する改善効果に優れた皮膚外用剤は得られなかった。
本発明は、上記のような従来技術の問題点を解決し、保湿効果および整肌効果に優れ、かつ、しみや皺に対する改善効果に優れた皮膚外用剤を提供することを目的とする。 An object of the present invention is to solve the above-described problems of the prior art, and to provide an external preparation for skin which is excellent in moisturizing effect and skin conditioning effect and excellent in improving stains and wrinkles.
本発明は、アミノ酸またはアミノ酸誘導体を配合することに加え、ユビキノンおよびN−アシル酸性アミノ酸エステルを配合することによって、保湿効果および整肌効果が優れ、かつ、しみや皺に対する改善効果に優れた皮膚外用剤を提供し、前期課題を解決したものである。 The present invention is a skin excellent in moisturizing effect and skin conditioning effect and excellent in improving stains and wrinkles by blending ubiquinone and N-acyl acidic amino acid ester in addition to blending amino acid or amino acid derivative. An external preparation was provided to solve the previous issues.
さらに、本発明は、上記アミノ酸またはアミノ酸誘導体、ユビキノンおよびN−アシル酸性アミノ酸エステルに加え、ピリドキシルセリンを配合することによって、保湿効果および整肌効果が優れ、かつしみや皺に対する改善効果に優れるという特性に加え、安定性をより一層高めた皮膚外用剤を提供したものである。 Furthermore, the present invention is excellent in moisturizing effect and skin conditioning effect, and in improving blemishes and wrinkles, by adding pyridoxylserine in addition to the amino acid or amino acid derivative, ubiquinone and N-acyl acidic amino acid ester. In addition to the above properties, the present invention provides an external preparation for skin with further improved stability.
本発明では、アミノ酸またはアミノ酸誘導体を配合することに加え、ユビキノンおよびN−アシル酸性アミノ酸エステルを配合することによって、保湿効果および整肌効果に優れ、かつしみおよび皺に対する改善効果が優れた皮膚外用剤を提供することができる。さらに、本発明では、それらに加え、ピリドキシルセリンを配合することによって、上記特性を保持しつつ、安定性をより一層高めた皮膚外用剤を提供することができる。 In the present invention, in addition to blending an amino acid or an amino acid derivative, by adding ubiquinone and an N-acyl acidic amino acid ester, it is excellent in moisturizing effect and skin conditioning effect, and has an excellent effect of improving stains and wrinkles An agent can be provided. Furthermore, in the present invention, by adding pyridoxylserine in addition to them, it is possible to provide an external preparation for skin that further enhances stability while maintaining the above characteristics.
以下、本発明について詳細に説明する。本発明において、アミノ酸またはアミノ酸誘導体は、保湿効果の向上に寄与させるために皮膚外用剤中に配合されるが、そのアミノ酸としては、例えば、アラニン、アルギニン、アスパラギン、アスパラギン酸、シトルリン、システイン、シスチン、グルタミン、グルタミン酸、グリシン、ヒスチジン、オキシプロリン、イソロイシン、ロイシン、リジン、メチオニン、オルニチン、フェニルアラニン、プロリン、セリン、スレオニン、トリプトファン、チロシン、バリンなどが挙げられ、それらのL体、D体またはDL体のいずれであってもよいし、また、それらの塩であってもよい。そのような塩としては、例えば、ナトリウム塩、カリウム塩、トリエタノールアミン塩、亜鉛塩などが挙げられる。 Hereinafter, the present invention will be described in detail. In the present invention, an amino acid or an amino acid derivative is blended in an external preparation for skin to contribute to the improvement of the moisturizing effect. Examples of the amino acid include alanine, arginine, asparagine, aspartic acid, citrulline, cysteine, and cystine. , Glutamine, glutamic acid, glycine, histidine, oxyproline, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, etc., their L-form, D-form or DL-form Any of these may be sufficient, and those salts may be sufficient. Examples of such salts include sodium salt, potassium salt, triethanolamine salt, zinc salt and the like.
また、アミノ酸誘導体としては、前述のアミノ酸を環化、アシル化またはエステル化したものであって、例えば、アセチルグルタミン酸、アセチルメチオニン、アセチルシステイン、N,N−ジアセチル−L−シスチンジメチルエステル、ピロリドンカルボン酸塩、アシルグルタミン酸塩、アシルグリシン塩、アシルアラニン塩、アシルアルギニンエチルエステル塩などが挙げられる。塩としては、例えば、ナトリウム塩、カリウム塩、トリエタノールアミン塩、亜鉛塩などが挙げられる。なかでもN,N−ジアセチル−L−シスチンジメチルエステル、ピロリドンカルボン酸亜鉛塩が好ましい。ただし、N−アシル酸性アミノ酸エステルを除く。 Examples of the amino acid derivatives include those obtained by cyclization, acylation or esterification of the above-mentioned amino acids, such as acetyl glutamic acid, acetyl methionine, acetyl cysteine, N, N-diacetyl-L-cystine dimethyl ester, pyrrolidone carboxyl. Acid salts, acyl glutamate salts, acyl glycine salts, acyl alanine salts, acyl arginine ethyl ester salts and the like. Examples of the salt include sodium salt, potassium salt, triethanolamine salt, zinc salt and the like. Of these, N, N-diacetyl-L-cystine dimethyl ester and pyrrolidone carboxylic acid zinc salt are preferred. However, N-acyl acidic amino acid esters are excluded.
上記アミノ酸またはアミノ酸誘導体は、それぞれ単独で用いてもよいし、または2種以上を併用してもよい。 The above amino acids or amino acid derivatives may be used alone or in combination of two or more.
そして、本発明において、上記アミノ酸またはアミノ酸誘導体は、その効果を適切に発現させるため、その配合量は、皮膚外用剤中において、0.001質量%以上にすることが好ましく、0.01質量%以上にするがより好ましく、0.1質量%以上とすることがさらに好ましく、また、アミノ酸またはアミノ酸誘導体の配合量を必要以上に多くすると、結晶が析出するおそれがあるので、50質量%以下にすることが好ましく、20質量%以下にすることがより好ましく、10質量%以下にすることがさらに好ましい。 In the present invention, the amino acid or amino acid derivative is preferably 0.001% by mass or more, and 0.01% by mass or more, in the external preparation for skin, in order to appropriately express the effect. More preferably, it is more preferably 0.1% by mass or more, and if the compounding amount of the amino acid or amino acid derivative is increased more than necessary, there is a possibility that crystals are precipitated. It is preferable to make it 20% by mass or less, more preferably 10% by mass or less.
本発明において用いるユビキノンとは、2,3−ジメトキシ−5−メチル−6−ポリプレニル−1,4−ベンゾキノンの側鎖のイソプレン単位が10のユビキノン類であり、ユビデカレノンまたは補酵素Q10として知られており、このユビキノンは、整肌性の向上や、しみおよび皺の改善に寄与するが、その効果を適切に発現させるためには、その効果を適切に発現させるためには、その配合量は0.0001質量%以上にすることが好ましく、0.01質量%以上にすることがより好ましく、0.03質量%以上にすることがさらに好ましく、また、ユビキノンの配合量を必要以上に多くすると、結晶化したり、製品の色が黄変するおそれがあるので、10質量%以下にすることが好ましく、1質量%以下にすることがより好ましく、1質量%以下にすることがさらに好ましい。 The ubiquinone for use in the present invention, a 2,3-dimethoxy-5-methyl-6-polyprenyl-1,4-ubiquinones isoprene units in the side chain is 10 benzoquinone, known as ubidecarenone or coenzyme Q 10 This ubiquinone contributes to the improvement of skin conditioning and the improvement of blemishes and wrinkles, but in order to express its effects appropriately, the compounding amount is It is preferably 0.0001% by mass or more, more preferably 0.01% by mass or more, further preferably 0.03% by mass or more, and when the amount of ubiquinone is increased more than necessary. , Since there is a risk of crystallization or yellowing of the product color, it is preferably 10% by mass or less, more preferably 1% by mass or less. It is more preferable to set it to mass% or less.
本発明において用いるN−アシル酸性アミノ酸エステルは、次の化学式(I)
で表されるものであって、特にN−アシル酸性ジエステルが好ましく、その好適な具体例としては、例えば、N−ラウロイルグルタミン酸ジ(コレステリル/ベヘニル/オクチルドデシル)、N−ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)、N−ラウロイルグルタミン酸ジ(フィトステリル/2−オクチルドデシル)、N−ラウロイルグルタミン酸ジ(オクチルドデシル/フィトステリル/ベヘニル)などが挙げられ、それらは、味の素株式会社から、それぞれ、「エルデュウCL−301」、「エルデュウCL−202」、「エルデュウPS−203」、「エルデュウPS−304」の商品名で市販されている。
The N-acyl acidic amino acid ester used in the present invention has the following chemical formula (I)
N-acyl acidic diesters are particularly preferred, and suitable specific examples thereof include, for example, N-lauroyl glutamate (cholesteryl / behenyl / octyldodecyl), N-lauroyl glutamate di (cholesteryl / Octyldodecyl), N-lauroylglutamate di (phytosteryl / 2-octyldodecyl), N-lauroylglutamate di (octyldodecyl / phytosteryl / behenyl) and the like from Ajinomoto Co., Inc., respectively. 301 "," L-Du CL-202 "," L-Du PS-203 ", and" L-Du PS-304 ".
そして、本発明において、このN−アシル酸性アミノ酸エステルは、ユビキノンとの併用により、保湿力や整肌性の向上に寄与し、また、安定性の向上にも寄与するが、その効果を適切に発現させるためには、その配合量は、0.01質量%以上にすることが好ましく、0.1質量%以上にすることがより好ましく、0.5質量%以上にすることがさらに好ましく、また、N−アシル酸性アミノ酸エステルの配合量を必要以上に多くすると、べたつくおそれがあるので、20質量%以下にすることが好ましく、10質量%以下にすることがより好ましく、5質量%以下にすることがさらに好ましい。 And in this invention, this N-acyl acidic amino acid ester contributes to the improvement of moisture retention and skin conditioning property, and also contributes to the improvement of stability by the combined use with ubiquinone. In order to achieve expression, the blending amount is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, further preferably 0.5% by mass or more, If the amount of N-acyl acidic amino acid ester is increased more than necessary, there is a risk of stickiness, so it is preferably 20% by mass or less, more preferably 10% by mass or less, and 5% by mass or less. More preferably.
本発明の皮膚外用剤は、上記のようなアミノ酸またはアミノ酸誘導体、ユビキノン、N−アシル酸性アミノ酸エステルを必須の配合成分とし、それら以下に、さらにピリドキシルセリンを配合することによって、上記必須の配合成分による効果を低下させることなく、アミノ酸またはアミノ酸誘導体の反応性に基づく安定性の低下を抑制して、皮膚外用剤としての安定性をより向上させることができる。 The skin external preparation of the present invention contains the above-mentioned essential compounding by using the above-mentioned amino acid or amino acid derivative, ubiquinone, N-acyl acidic amino acid ester as an essential compounding component, and further adding pyridoxylserine below them. Without reducing the effects of the components, the stability as an external preparation for skin can be further improved by suppressing the decrease in stability based on the reactivity of the amino acid or amino acid derivative.
このピリドキシルセリンは、次の化学式(II)
本発明の皮膚外用剤は、水または水を主剤とする水性液(水を10質量%以上含有)に、上記アミノ酸またはアミノ酸誘導体、ユビキノン、N−アシル酸性アミノ酸エステルを配合し、要すれば、それらに加えて、ピリドキシルセリンを配合することによって調整されるが、それら以外にも、それらの効果を損なわない範囲で、一般に皮膚外用剤基剤と呼ばれる配合剤、例えば、アルコール、金属イオン封鎖剤、増粘剤、油分、薬剤、香料、着色料、紫外線吸収剤、界面活性剤、防腐剤などを配合することができる。 The skin external preparation of the present invention contains the above-mentioned amino acid or amino acid derivative, ubiquinone, N-acyl acidic amino acid ester in water or an aqueous liquid mainly containing water (containing 10% by mass or more of water). In addition to these, it is adjusted by blending pyridoxylserine, but in addition to these, in a range that does not impair their effects, a blending agent generally called a skin external preparation base, such as alcohol, sequestering metal ions Agents, thickeners, oils, chemicals, fragrances, colorants, ultraviolet absorbers, surfactants, preservatives, and the like can be blended.
上記アルコールとしては、例えばエタノール、イソプロパノール等の1価のアルコール、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、1,2−ペンタンジオール等の2価のアルコール、グリセリン等の3価のアルコール、ペンタエリスリトール等の4価のアルコール、キシリトール等の5価のアルコール、ソルビトール、マンニトール等の6価のアルコール、マルトール、キシリトース、デンプン分解糖還元アルコール等の糖アルコール等が挙げられる。 Examples of the alcohol include monovalent alcohols such as ethanol and isopropanol, divalent alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and 1,2-pentanediol, trivalent alcohols such as glycerin, Examples include tetravalent alcohols such as pentaerythritol, pentavalent alcohols such as xylitol, hexavalent alcohols such as sorbitol and mannitol, and sugar alcohols such as maltol, xylitol, and amylolytic sugar-reducing alcohol.
乳化剤としては、例えば、POE(POE=ポリオキシエチレン、以下同様)−ソルビタンモノオレエート、POE−ソルビタンモノステアレート、POE−ソルビタンモノオレート、POE−ソルビタンテトラオレエートなどのPOEソルビタン脂肪酸エステル類、POE−ソルビットモノラウレート、POE−ソルビットモノオレエート、POE−ソルビットペンタオレエート、POE−ソルビットモノステアレートなどのPOE−ソルビット脂肪酸エステル類、POE−グリセリンモノステアレート、POE−グリセリンモノイソステアレート、POE−グリセリントリイソステアレートなどのPOE−グリセリン脂肪酸エステル類、POE−モノオレエート、POE−ジステアレート、POE−モノジオレエート、システアリン酸エチレングリコールなどのPOE−脂肪酸エステル類、POE−ラウリルエーテル、POE−オレイルエーテル、POE−ステアリルエーテル、POE−ベヘニルエーテル、POE−2−オクチルドデシルエーテル、POE−コレスタノールエーテルなどのPOE−アルキルエーテル類、POE−オクチルフェニルエーテル、POE−ノニルフェニルエーテル、POE−ジノニルフェニルエーテルなどのPOE−アルキルフェニルエーテル類、ブルロニックなどのプロアロニック型類、POE・POP(POP=ポリオキシプロピレン、以下同様)−セチルエーテル、POE・POP−2−デシルテトラデシルエーテル、POE・POP−モノブチルエーテル、POE・POP−水添ラノリン、POE・POP−グリセリンエーテルなどのPOE・POP−アルキルエーテル類、POE−ヒマシ油、POE−硬化ヒマシ油、POE−硬化ヒマシ油モノイソステアレート、POE−硬化ヒマシ油トリイソステアレート、POE−硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、POE−硬化ヒマシ油マレイン酸などのPOE−ヒマシ油硬化ヒマシ油誘導体、POE−ソルビットミツロウなどのPOE−ミツロウ・ラノリン誘導体、ショ糖脂肪酸エステル、トリオレイルリン酸などが挙げられる。 Examples of the emulsifier include POE sorbitan fatty acid esters such as POE (POE = polyoxyethylene, hereinafter the same) -sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, POE-sorbitan tetraoleate, POE-sorbite fatty acid esters such as POE-sorbitol monolaurate, POE-sorbitol monooleate, POE-sorbitol pentaoleate, POE-sorbitol monostearate, POE-glycerol monostearate, POE-glycerol monoisostearate POE-glycerin fatty acid esters such as POE-glycerin triisostearate, POE-monooleate, POE-distearate, POE-monodiolate, stearic acid ester POE-fatty acid esters such as lenglycol, POE-alkyl ethers such as POE-lauryl ether, POE-oleyl ether, POE-stearyl ether, POE-behenyl ether, POE-2-octyldodecyl ether, POE-cholestanol ether , POE-octylphenyl ether, POE-nonylphenyl ether, POE-alkylphenyl ethers such as POE-dinonylphenyl ether, proalonic types such as brulon, POE · POP (POP = polyoxypropylene, the same applies hereinafter) -cetyl PO such as ether, POE · POP-2-decyltetradecyl ether, POE · POP-monobutyl ether, POE · POP-hydrogenated lanolin, POE · POP-glycerin ether POP-alkyl ethers, POE-castor oil, POE-hardened castor oil, POE-hardened castor oil monoisostearate, POE-hardened castor oil triisostearate, POE-hardened castor oil monopyroglutamic acid monoisostearic acid diester POE-castor oil-hardened castor oil derivatives such as POE-hardened castor oil maleic acid, POE-beeswax lanolin derivatives such as POE-sorbit beeswax, sucrose fatty acid ester, trioleyl phosphate and the like.
金属イオン封鎖剤としては、例えば1−ヒドロキシエタン−1,1−ジフォスホン酸、1−ヒドロキシエタン−1,1−ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等が挙げられる。 Examples of sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, tetrasodium edetate, Examples include sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid.
増粘剤としては、例えばアラビアガム、カラギーナン、カラヤガム、トラガカントガム、キャロブガム、クインスシード、カゼイン、デキストリン、ゼラチン、ペクチン酸ナトリウム、アラギン酸ナトリウム、メチルセルロース、エチルセルロース、カルボキシメチルセルロース(CMC)、ヒドロキシエチルセルロース、ヒドロキシエチルセルロール、ヒロドキシプロピルセルロース、ポリビニルアルコール(PVA)、ポリビニルメチルエーテル(PVM)、ポリビニルピロリドン(PVP)、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ローカストビーンガム、グアーガム、タマリンガム、ジアルキルジメチルアンモニウム硫酸セルロース、キサンタンガム、ケイ酸アルミニウムマグネシウム、ベントナイト、ヘクトライト等が挙げられる。 Examples of thickeners include gum arabic, carrageenan, gum karaya, gum tragacanth, carob gum, quince seed, casein, dextrin, gelatin, sodium pectate, sodium alginate, methylcellulose, ethylcellulose, carboxymethylcellulose (CMC), hydroxyethylcellulose, hydroxyethyl Cellulol, hydroxypropyl cellulose, polyvinyl alcohol (PVA), polyvinyl methyl ether (PVM), polyvinyl pyrrolidone (PVP), sodium polyacrylate, carboxyvinyl polymer, locust bean gum, guar gum, tamarin gum, dialkyldimethylammonium cellulose sulfate Xanthan gum, magnesium aluminum silicate, bentonite, hectorite, etc.
油分としては、例えばアボガト油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等の液体油脂、脂、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚油、モクロウ、硬化ヒマシ油等の固体油脂、ミツロウ、カンデリラロウ、綿ロウ、カルナバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、セラックロウ、POE−ラノリンアルコールアセテート、POE−コレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE−水素添加ラノリンアルコールエーテル等のロウ類、流動パラフィン、オゾケライト、スクワレン、ピリスタン、パファフィン、セレシン、スクワラン、ワセリン、マイクロクリスタリンワックス等の炭化水素が挙げられる。 Examples of oils include avocato oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, flaxseed oil, saury Flower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, etc. Liquid oil, fat, cacao butter, palm oil, horse fat, hydrogenated palm oil, palm oil, beef tallow, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, owl kernel oil, hydrogenated oil, cow leg oil, molasses , Solid fats such as hardened castor oil, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nuka wax, Waxes such as Norin, Kapok wax, Lanolin acetate, Liquid lanolin, Sugar cane wax, Lanolin fatty acid isopropyl, Hexyl laurate, Shellac wax, POE-lanolin alcohol acetate, POE-cholesterol ether, lanolin fatty acid polyethylene glycol, POE-hydrogenated lanolin alcohol ether , Hydrocarbons such as liquid paraffin, ozokerite, squalene, pyristan, puffafin, ceresin, squalane, petrolatum, microcrystalline wax and the like.
そして、本発明の皮膚外用剤の剤型は、特に限定されることなく、例えば、液状、乳液状、ゲル状、クリーム状、懸濁状のいずれでもよい。本発明の皮膚外用剤は、通常、肌と呼ばれる頭皮以外の皮膚に対して用いられるが、頭皮に対して用いてもよい。 And the dosage form of the external preparation for skin of this invention is not specifically limited, For example, any of liquid form, emulsion, gel form, cream form, and suspension form may be sufficient. The external preparation for skin of the present invention is usually used for skin other than the scalp called skin, but may be used for the scalp.
次に実施例を挙げて本発明をより具体的に説明する。ただし、本発明はこれらの実施例のみに限定されるものではない。 Next, the present invention will be described more specifically with reference to examples. However, the present invention is not limited to only these examples.
実施例1〜2および比較例1〜3
表1に示す組成で5種類のクリームタイプの皮膚外用剤を調製した。表中における各成分の配合量は質量%で表示したものであり、精製水の配合量を示す残余とは、全体を100質量%にするのに必要な配合量をいう。そして、それらは、以下の実施例や比較例において配合量を示す際においても同様である。なお、これら実施例1〜2などでは、N−アシル酸性アミノ酸エステルは4種類の混合物を0.8質量%配合するが、その内訳は次の通りである。
N−アシル酸性アミノ酸エステルの内訳:
種類は下記の4種類で、その量はいずれも0.2質量%ずつで、計0.8質量%である。
N−ラウロイルグルタミン酸ジ(フィトステリル・2−オクチルドデシル)
N−ラウロイルグルタミン酸ジ(オキウチルドデシル/フィトステリル/ベヘニル)
N−ラウロイルグルタミン酸ジ(コレステリル/ベヘニル/オクリルドデシル)
N−ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)
Examples 1-2 and Comparative Examples 1-3
Five cream type skin external preparations were prepared with the compositions shown in Table 1. The amount of each component in the table is expressed in mass%, and the remainder indicating the amount of purified water refers to the amount required to make the whole 100 mass%. And when they show a compounding quantity in a following example and a comparative example, they are the same. In Examples 1 and 2 and the like, the N-acyl acidic amino acid ester contains 0.8% by mass of four types of mixtures. The breakdown is as follows.
Breakdown of N-acyl acidic amino acid esters:
There are the following four types, and the amount is 0.2% by mass, and the total is 0.8% by mass.
N-lauroyl glutamate di (phytosteryl 2-octyldodecyl)
N-Lauroylglutamate di (Okitildodecyl / Phytosteryl / Behenyl)
N-lauroylglutamate di (cholesteryl / behenyl / octyldodecyl)
N-lauroylglutamate di (cholesteryl / octyldodecyl)
上記のようにして調製した実施例1〜2および比較例1〜3の皮膚外用剤をそれぞれ10人の専門パネラーの目じりに4週間にわたって毎日2回約50mgずつ塗布し、その保湿効果、整肌効果、しみに対する改善効果、皺に対する改善効果を評価させた。その評価を表1に示す。評価は下記の基準によって5段階に点数化し、表1への表示にあたっては、平均点が4点以上を◎、3点以上4点未満を○、2点以上3点未満を△、2点未満を×と、記号化して表示した。
評価基準:
効果が顕著であった・・・5点
効果があった・・・・・・4点
わずかに効果あった・・・3点
効果が感じられない・・・2点
悪化した・・・・・・・・1点
About 50 mg of the topical skin preparations of Examples 1 and 2 and Comparative Examples 1 to 3 prepared as described above were each applied to the eyes of 10 professional panelists twice a day for 4 weeks. The effect, the improvement effect on the stain, and the improvement effect on the wrinkle were evaluated. The evaluation is shown in Table 1. Evaluation is scored in five levels according to the following criteria, and when displayed in Table 1, the average score is 4 or more: ◎ 3 or more but less than 4 ○, 2 or more but less than 3 Was symbolized as x.
Evaluation criteria:
The effect was remarkable ... 5 points The effect was ... 4 points The effect was slightly ... 3 points The effect was not felt ... 2 points was deteriorated ... ... 1 point
また、上記実施例1〜2および比較例1〜3の皮膚外用剤について下記に示す方法にて安定性を評価した。その結果も表1に示す。 Moreover, stability was evaluated by the method shown below about the skin external preparation of the said Examples 1-2 and Comparative Examples 1-3. The results are also shown in Table 1.
安定性の評価方法:
実施例1〜2および比較例1〜3の皮膚外用剤をそれぞれ別々のガラス容器に入れ、50℃で30日間保存した後、目視により変色の有無を観察するとともに、ガラス容器の蓋をとって、臭いをかいで、変臭の有無を調べた。そして、その結果の表1への表示にあたっては、明らかな変色または変臭があるものを×、変色または変臭があるものを△、変色または変臭が非常にわずかであるものを○、まったく変化しないものを◎と、記号化して表示した。
Stability evaluation method:
After putting the skin external preparations of Examples 1-2 and Comparative Examples 1-3 in separate glass containers and storing them at 50 ° C. for 30 days, the presence or absence of discoloration is visually observed, and the lid of the glass container is taken. The smell was checked and the presence or absence of a strange odor was examined. In the display of the results in Table 1, when there is an obvious discoloration or odor, ×, when there is discoloration or odor, Δ, when there is very little discoloration or odor, Those that do not change are symbolized as ◎.
表1から明らかなように、アミノ酸(L−アルギニン、グリシン、アラニン、L−セリンおよびL−プロリン)、アミノ酸誘導体(ピロリドンカルボン酸亜鉛)に加え、ユビキノンとN−アシル酸性アミノ酸エステルを配合した実施例1は、保湿効果および整肌効果に優れ、かつ、しみおよび皺に対する改善効果が優れ、安定性に関しても、N−アシル酸性アミノ酸エステルを配合していない比較例1に比べて向上していた。 As is clear from Table 1, in addition to amino acids (L-arginine, glycine, alanine, L-serine and L-proline), amino acid derivatives (zinc pyrrolidone carboxylate), ubiquinone and N-acyl acidic amino acid ester were blended. Example 1 was excellent in moisturizing effect and skin conditioning effect, excellent in improving stains and wrinkles, and improved in stability as compared with Comparative Example 1 in which no N-acyl acidic amino acid ester was blended. .
そして、実施例1の各成分に加え、さらにピリドキシルセリンを配合した実施例2は実施例1と同様に、保湿効果および整肌効果に優れ、かつ、しみおよび皺に対する改善効果に優れる上に、安定性が実施例1よりさらに向上していた。 And, in addition to each component of Example 1, Example 2 further blended with pyridoxylserine is excellent in the moisturizing effect and skin conditioning effect as well as in Example 1, and is excellent in the effect of improving stains and wrinkles. The stability was further improved from that of Example 1.
これに対して、アミノ酸およびユビキノンは配合しているものの、N−アシル酸性アミノ酸エステルを配合していない比較例1は、保湿効果および整肌効果が充分でなく、しかも、安定性が悪く、また、アミノ酸およびN−アシル酸性アミノ酸エステルは配合しているものの、ユビキノンを配合していない比較例2は、しみや皺に対する改善効果が充分でなく、安定性も実施例のものに比べて劣っていた。 In contrast, Comparative Example 1 in which an amino acid and ubiquinone were blended but no N-acyl acidic amino acid ester was blended did not have sufficient moisturizing effect and skin conditioning effect, and had poor stability, In Comparative Example 2 in which an amino acid and an N-acyl acidic amino acid ester were blended, but no ubiquinone was blended, the effect of improving stains and wrinkles was not sufficient, and the stability was inferior to that of the Examples. It was.
そして、アミノ酸とピリドキシルセリンは配合していないものの、ユビキノンやN−アシル酸性エステルを配合していない比較例3は、保湿効果、整肌効果、しみや皺に対する改善効果のいずれもが充分でなかった。 And although the comparative example 3 which does not mix | blend an amino acid and pyridoxyl serine but does not mix | blend ubiquinone or N-acyl acidic ester, all of the moisturizing effect, the skin conditioning effect, and the improvement effect with respect to a spot and a wrinkle are enough. There wasn't.
実施例3
下記の組成により化粧水タイプの皮膚外用剤を調製した。
質量%
L−セリン 1.0
L−アスパラギン酸ナトリウム 1.0DL−ピロリドンカルボン酸ナトリウム 1.0
トリメチルグリシン 1.0
N−ヤシ油脂肪酸アシル−L−アルギニン 0.1
・DL−ピロリドンカルボン酸塩
ユビキノン 0.03
N−ラウロイルグルタミン酸ジ(オクチルドデシル 1.0
/フィトステリル/ベヘニル)(商品名「エルデュウPS−304」)
ピリドキシルセリン 0.05
グリセリン 10.0
1,3−ブチレングリコール 5.0
ポリオキシエチレン硬化ヒマシ油 1.0
ピログルタミン酸イソステアリン酸ジエステル
フェノキシエタノール 0.2
メチルパラベン 0.1
エタノール 3.0
ヒドロキシエチルセルロース 0.05
香料 適量
精製水 残余
Example 3
A skin lotion type skin external preparation was prepared with the following composition.
mass%
L-serine 1.0
L-sodium aspartate 1.0 DL-pyrrolidone sodium carboxylate 1.0
Trimethylglycine 1.0
N-coconut oil fatty acid acyl-L-arginine 0.1
DL-pyrrolidone carboxylate ubiquinone 0.03
N-lauroylglutamate di (octyldodecyl 1.0
/ Phytosteryl / Behenyl) (Brand name "El Dew PS-304")
Pyridoxyl serine 0.05
Glycerin 10.0
1,3-butylene glycol 5.0
Polyoxyethylene hydrogenated castor oil 1.0
Pyroglutamic acid isostearic acid diester phenoxyethanol 0.2
Methylparaben 0.1
Ethanol 3.0
Hydroxyethyl cellulose 0.05
Perfume Appropriate amount of purified water
実施例4
下記の組成により乳液タイプの皮膚外用剤を調製した。
質量%
アセチルシステイン 0.1
バリン 0.1
ロイシン 0.1
イソロイシン 0.1
ユビキノン 0.01
N−ラウロイルグルタミン酸ジ(コレステリル/ベヘニル 1.0
/オクチルドデシル)(商品名「エルデュウCL−301」)
N−ラウロイルグルタミン酸ジ(フィトステリル 0.5
/2-オクチルドデシル)(商品名「エルデュウPS−203」)
ピリドキシルセリン 0.1
流動バラフィン 7.0
スクワラン 5.0
ミリスチン酸イソセチル 3.0
セタノール 0.5
モノステアリン酸POE(20)ソルビタン 2.5
キサンタンガム 0.1
ジメチコン 4.0
濃グリセリン 5.0
フェノキシエタノール 0.2
グリチルリチン酸ジカリウム 0.1
dl−α―トコフェロール 0.1
油溶性甘草エキス 0.01
精製水 残余
Example 4
An emulsion type skin external preparation was prepared with the following composition.
mass%
Acetylcysteine 0.1
Valine 0.1
Leucine 0.1
Isoleucine 0.1
Ubiquinone 0.01
N-lauroylglutamate di (cholesteryl / behenyl 1.0
/ Octildodecyl) (Brand name "El Deu CL-301")
N-lauroyl glutamate di (phytosteryl 0.5
/ 2-octyldodecyl) (Brand name "El Dew PS-203")
Pyridoxyl serine 0.1
Flowing ballaffin 7.0
Squalane 5.0
Isocetyl myristate 3.0
Cetanol 0.5
Monostearic acid POE (20) sorbitan 2.5
Xanthan gum 0.1
Dimethicone 4.0
Concentrated glycerin 5.0
Phenoxyethanol 0.2
Dipotassium glycyrrhizinate 0.1
dl-α-tocopherol 0.1
Oil-soluble licorice extract 0.01
Purified water residue
実施例5
下記の組成によりクリームタイプの皮膚外用剤を調製した。
質量%
L−アルギニン 0.5
L−リジン 0.1
L−グルタミン酸 0.1
L−トリプトファン 0.1
L−ヒスチジン 0.05
L−セリン 1.0
ユビキノン 0.1
N−ラウロイルグルタミン酸ジ(コレステリル 2.0
/オクチルドデシル)(商品名「エルデュウCL−202」)
ピリドキシルセリン 0.1
ホホバ油 3.0
スクワラン 5.0
ワセリン 5.0
ベヘニルアルコール 2.0
テトラオレイン酸POE(20)ソビタン 3.0
ラウロイルリジン 1.0
カルボキシビニルポリマー 0.5
モノステアリン酸グリセリル 1.0
ヒアルロン酸ナトリウム 0.01
香料 適量
色素 適量
精製水 残余
Example 5
A cream type skin external preparation was prepared with the following composition.
mass%
L-Arginine 0.5
L-lysine 0.1
L-glutamic acid 0.1
L-tryptophan 0.1
L-histidine 0.05
L-serine 1.0
Ubiquinone 0.1
N-lauroylglutamate di (cholesteryl 2.0)
/ Octildodecyl) (Brand name "El Deu CL-202")
Pyridoxyl serine 0.1
Jojoba oil 3.0
Squalane 5.0
Vaseline 5.0
Behenyl alcohol 2.0
Tetraoleic acid POE (20) Sobitan 3.0
Lauroyllysine 1.0
Carboxyvinyl polymer 0.5
Glyceryl monostearate 1.0
Sodium hyaluronate 0.01
Perfume Appropriate amount of pigment Appropriate amount of purified water
上記実施例3〜5の皮膚外用剤について、それらの保湿効果、整肌効果、しみおよび皺に対する改善効果、安定性について、実施例1と同様に調べたところ、実施例1〜2と同様に、いずれも良好であった。 About the external preparations for skin of Examples 3 to 5 above, their moisturizing effect, skin conditioning effect, improvement effect against stains and wrinkles, and stability were examined in the same manner as in Example 1. As in Examples 1 and 2, Both were good.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006173908A JP2008001654A (en) | 2006-06-23 | 2006-06-23 | External preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006173908A JP2008001654A (en) | 2006-06-23 | 2006-06-23 | External preparation for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008001654A true JP2008001654A (en) | 2008-01-10 |
Family
ID=39006338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006173908A Pending JP2008001654A (en) | 2006-06-23 | 2006-06-23 | External preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008001654A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008088113A (en) * | 2006-10-03 | 2008-04-17 | Ss Pharmaceut Co Ltd | Whitening composition |
| JP2009249342A (en) * | 2008-04-07 | 2009-10-29 | Noevir Co Ltd | Skincare preparation for external use |
| WO2011158679A1 (en) * | 2010-06-17 | 2011-12-22 | 株式会社 資生堂 | Skin improving dermo-cosmetics |
| WO2011158678A1 (en) * | 2010-06-17 | 2011-12-22 | 株式会社 資生堂 | Oil-in-water type emulsion skin cosmetic |
| WO2012017733A1 (en) * | 2010-08-05 | 2012-02-09 | 株式会社 資生堂 | Skin cosmetic |
| JP2013136545A (en) * | 2011-12-28 | 2013-07-11 | Kao Corp | Emulsified composition |
| JP2013256472A (en) * | 2012-06-13 | 2013-12-26 | Yakult Honsha Co Ltd | Thickening composition containing acylated amino acid |
| JPWO2017069128A1 (en) * | 2015-10-19 | 2018-08-09 | 味の素株式会社 | Moisturizer and cosmetics containing the same |
| JP2023147133A (en) * | 2022-03-29 | 2023-10-12 | 株式会社ピカソ美化学研究所 | Composition for skin |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61289029A (en) * | 1985-06-11 | 1986-12-19 | Shiseido Co Ltd | Agent for alleviating pigmentation |
| JPH07258019A (en) * | 1994-03-18 | 1995-10-09 | Ajinomoto Co Inc | Cosmetic |
| JP2004099564A (en) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | Humectant cosmetic |
| JP2004224742A (en) * | 2003-01-23 | 2004-08-12 | Umeken:Kk | Skin care preparation |
| JP2005255634A (en) * | 2004-03-12 | 2005-09-22 | Ajinomoto Healthy Supply Kk | Skin care preparation for external use |
| JP2005298370A (en) * | 2004-04-07 | 2005-10-27 | Shiseido Co Ltd | Skin preparation for external use for preventing aging of skin |
| JP2007153866A (en) * | 2005-11-09 | 2007-06-21 | Yoshida Kikai Co Ltd | Emulsion type cosmetic |
-
2006
- 2006-06-23 JP JP2006173908A patent/JP2008001654A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61289029A (en) * | 1985-06-11 | 1986-12-19 | Shiseido Co Ltd | Agent for alleviating pigmentation |
| JPH07258019A (en) * | 1994-03-18 | 1995-10-09 | Ajinomoto Co Inc | Cosmetic |
| JP2004099564A (en) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | Humectant cosmetic |
| JP2004224742A (en) * | 2003-01-23 | 2004-08-12 | Umeken:Kk | Skin care preparation |
| JP2005255634A (en) * | 2004-03-12 | 2005-09-22 | Ajinomoto Healthy Supply Kk | Skin care preparation for external use |
| JP2005298370A (en) * | 2004-04-07 | 2005-10-27 | Shiseido Co Ltd | Skin preparation for external use for preventing aging of skin |
| JP2007153866A (en) * | 2005-11-09 | 2007-06-21 | Yoshida Kikai Co Ltd | Emulsion type cosmetic |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008088113A (en) * | 2006-10-03 | 2008-04-17 | Ss Pharmaceut Co Ltd | Whitening composition |
| JP2009249342A (en) * | 2008-04-07 | 2009-10-29 | Noevir Co Ltd | Skincare preparation for external use |
| WO2011158679A1 (en) * | 2010-06-17 | 2011-12-22 | 株式会社 資生堂 | Skin improving dermo-cosmetics |
| WO2011158678A1 (en) * | 2010-06-17 | 2011-12-22 | 株式会社 資生堂 | Oil-in-water type emulsion skin cosmetic |
| JP2012020989A (en) * | 2010-06-17 | 2012-02-02 | Shiseido Co Ltd | Skin improving dermo-cosmetic |
| JP2012020988A (en) * | 2010-06-17 | 2012-02-02 | Shiseido Co Ltd | Oil-in-water type emulsion skin cosmetic |
| US8697750B2 (en) | 2010-06-17 | 2014-04-15 | Shiseido Company, Ltd. | Oil-in-water type emulsion skin cosmetic |
| WO2012017733A1 (en) * | 2010-08-05 | 2012-02-09 | 株式会社 資生堂 | Skin cosmetic |
| JP2013136545A (en) * | 2011-12-28 | 2013-07-11 | Kao Corp | Emulsified composition |
| JP2013256472A (en) * | 2012-06-13 | 2013-12-26 | Yakult Honsha Co Ltd | Thickening composition containing acylated amino acid |
| JPWO2017069128A1 (en) * | 2015-10-19 | 2018-08-09 | 味の素株式会社 | Moisturizer and cosmetics containing the same |
| JP2023147133A (en) * | 2022-03-29 | 2023-10-12 | 株式会社ピカソ美化学研究所 | Composition for skin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7867961B2 (en) | Wash composition | |
| US20130071535A1 (en) | Food and flavorant compositions comprising renewably-based, biodegradable 1,3-propanediol | |
| JPH10130128A (en) | Cosmetics | |
| TWI484980B (en) | Emulsified cosmetics | |
| JP5637987B2 (en) | Preservative composition | |
| JP6118546B2 (en) | Oil-in-water emulsion composition | |
| JP2008001654A (en) | External preparation for skin | |
| JP2540895B2 (en) | Oral composition | |
| JP6522908B2 (en) | Composition for external use | |
| JPH0228105A (en) | Cosmetic | |
| JP6729570B2 (en) | Cosmetic composition containing acylproline | |
| WO2016039407A1 (en) | Moisturizer and cosmetic containing same | |
| JP2665976B2 (en) | Cosmetics | |
| JP6575517B2 (en) | Cosmetic composition containing 3-O-alkyl-L-ascorbic acid or a salt thereof | |
| US9464110B2 (en) | Acyl dipeptide derivative | |
| JP2013212999A (en) | Cosmetic for nail | |
| JP5311704B2 (en) | Skin cosmetics | |
| JP2565516B2 (en) | Topical skin | |
| JP2019151605A (en) | Skin external preparation and aqueous solution | |
| JP6338435B2 (en) | Topical skin preparation | |
| US5985922A (en) | Amino acid derivatives and active oxygen-resisting agent | |
| JP2006160608A (en) | Hair nourishing composition | |
| JPH0533922B2 (en) | ||
| JP7763039B2 (en) | cosmetics | |
| JP2644353B2 (en) | Whitening cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090422 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110328 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110510 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111011 |